COVID-19口罩强制令对乳房切除术后组织扩张并发症发生率的影响
本研究回顾性分析了同一机构2017年(口罩强制令前)和2021年(强制令后)乳房切除术后行单侧或双侧组织扩张的患者,比较两组并发症发生率。结果显示口罩强制令前后主要并发症率(26.3% vs 30.6%,P=0.495)和次要并发症率(30.5% vs 26.5%,P=0.495)均无显著差异。作者认为口罩使用对门诊组织扩张操作并发症率无显著影响,是否佩戴口罩由操作者自行决定。
要点
- 口罩强制令前后主要并发症率分别为26.3%和30.6%,无显著差异(P=0.495)。
- 口罩强制令前后次要并发症率分别为30.5%和26.5%,无显著差异(P=0.495)。
- 作者认为是否在操作时佩戴口罩由操作者酌情决定。
核心结论
- 口罩使用对门诊组织扩张操作的并发症率无显著影响。
- 是否在操作过程中佩戴口罩仍由操作者酌情决定。
研究设计与样本
- 经机构审查委员会批准的回顾性研究,纳入同一机构2017年(COVID-19口罩强制令前)和2021年(强制令实施后)乳房切除术后接受单侧或双侧组织扩张的所有患者。
- 口罩强制令前组118例,口罩强制令后组147例。
主要发现
- 两组年龄、体重指数、吸烟状态和糖尿病患病率无差异(P>0.05)。
- 口罩强制令后组行双侧再造的比例高于强制令前组(70.7% vs 55.9%,P=0.014)。
- 口罩强制令前组与强制令后组主要并发症率分别为26.3%与30.6%,无显著差异(P=0.495)。
- 口罩强制令前组与强制令后组次要并发症率分别为30.5%与26.5%,无显著差异(P=0.495)。
临床怎么用
- 作者认为,是否在组织扩张操作过程中佩戴口罩由操作者酌情决定。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Tissue expansion is a commonly used breast reconstructive strategy. Although the procedure is regarded as safe, tissue expander to implant-based breast reconstruction is reported to have the highest rates of postoperative infection among plastic surgery operations. During the COVID-19 pandemic, face masks were required at all hospital facilities at our institution. The purpose of this study is to investigate the effects of COVID-19 mask mandate on in-office breast tissue expansion procedures. METHODS: An institutional review board-approved, retrospective review was completed on all patients who underwent unilateral or bilateral tissue expansion following mastectomy at a single institution in 2017 (prior to the COVID-19 mask mandate) and 2021 (following implementation of the mandate). Variables included were demographics, procedure information, and postoperative outcomes. RESULTS: The analysis included 118 patients in the premandate group and 147 patients in the postmandate group. There was no difference in age, body mass index, smoking status, or diabetes mellitus between the 2 groups ( P > 0.05). More patients in the postmandate group underwent bilateral reconstruction as opposed to unilateral when compared with the premandate group (70.7% vs 55.9%, P = 0.014). There were no differences in major complication rate (26.3% vs 30.6%, P = 0.495) or minor complication rate 30.5% vs 26.5%, P = 0.495) between the pre-mask and post-mask mandate groups. CONCLUSION: Our results demonstrated that the use of face masks did not play a significant role in complication rates relating to in-office tissue expansion procedures. It remains up to the discretion and comfortability of the provider if masks should be worn during the procedure.
引用
- Braswell AC, Bald M, Fonseca G, et al. The Effects of the COVID-19 Mask Mandate on Complication Rates in Postmastectomy Tissue Expansion. Ann Plast Surg. 2024. PMID: 39356175. doi:10.1097/SAP.0000000000004109
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。